PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cocaine discovery could pave way for treatment for substance abuse

2024-08-07
(Press-News.org) You have probably heard of dopamine. The substance also known as the “feel-good hormone”.

Drugs such as cocaine cause a surge of dopamine in the brain. Normally, a protein in the brain called the dopamine transporter (DAT) helps regulate dopamine levels and prevent the brain from thinking that every experience is pleasurable.

However, when affected by cocaine, the brain is unable to regulate dopamine levels. Previously, researchers did not know how cocaine affects the different transporters in the brain, but a new study from the University of Copenhagen has changed that.

“We have learned how cocaine binds to the dopamine transporter, which is a protein responsible for regulating dopamine levels in the brain. What we did was describe the structure of the dopamine transporter, which gave us molecular-level insight into how it is inhibited by cocaine,” says PhD Student Jeppe Cederholm Nielsen, who is one of the researchers responsible for the new study.

Our dream is to find a medical treatment for cocaine abuse.

Professor Claus Løland

When the brain is unable to regulate dopamine levels, everything we do seems great, the researchers explain. Cocaine does not make the brain release more dopamine, but it prevents it from regulating and removing dopamine.

“When we experience something as pleasurable, it is because the dopamine that is released in the brain stimulates the reward centre. The role of the dopamine transporter is to stop this process by removing dopamine,” says Professor Claus Løland from the Department of Neuroscience at the University of Copenhagen and adds:

“When cocaine blocks the dopamine transporter, dopamine will continue to stimulate the reward centre – even though the experience itself is not particularly pleasurable. In other words, we become incapable of distinguishing between what is truly pleasurable and what is not, and then all types of input given by our senses will seem great. You could say that cocaine tricks the brain. It is a form of chemical brainwashing.”

World’s most powerful microscope provides answers To understand what cocaine does to the brain, the researchers studied the dopamine transporter, which is a very small protein – too small to be studied in a standard microscope.

“We have used the most powerful microscope in the world to study the structure of the atoms of the dopamine transporter. We have learned how cocaine binds and thus blocks this function, and this is important if we want to be able to stop cocaine from affecting the brain,” says Jeppe Cederholm Nielsen and adds:

“These proteins are so tiny that they are invisible under a microscope – even this extremely powerful microscope. But we used a couple of tricks to work around this and make them visible.”

Want to develop treatment for substance abuse There is currently no for cocaine abuse, but in the long run the researchers want to that can help people get rid of their addictions.

“Our dream is to find a medical treatment for cocaine abuse. While fewer and fewer people are addicted to drugs in general, an increasing number of people become addicted to cocaine. It is one of the most addictive substances out there, and it is becoming more and more affordable,” says Claus Løland.

The researchers hope their new knowledge of the function of the dopamine transporter will help them understand addiction in general.

“Perhaps we will be able to treat addiction to a number of things, not just cocaine. For instance, addiction to gambling or other substances, which is also caused by a release of dopamine into the brain,” says Claus Løland and adds:

“If we were able to design a drug for addiction in general, we would be able to help a lot of people.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Link discovered between sensory neurons and breast cancer metastasis

2024-08-07
Cancer doesn’t grow in a vacuum—each tumor grows in a particular microenvironment within the body and spreads through a tangled web of vasculature and nerves. Scientists have come to understand that the most potent therapies address cancer in context—accounting for both the tumor and the support structure that forms around it. Now, a new paper in Nature reveals that the activation of sensory nerves within breast tumors is playing a critical role in promoting not only cancer growth but also its spread, known as metastasis. The findings—that sensory neurons ...

Plants show surprising diversity in arid landscape

Plants show surprising diversity in arid landscape
2024-08-07
Understanding how plants cope with climatic extremes and grazing pressure is important for reliable prediction about future biodiversity and the functioning of dryland ecosystems[1]. An international team, coordinated by KAUST’s Fernando Maestre, has assessed how 20 chemical and morphological plant functional traits jointly respond to changes in aridity and grazing pressure across global drylands. Increasing aridity and grazing pressure could be expected to reduce the level of plant diversity. However, the diversity of plant traits — including key traits linked to nutrient cycling such as specific leaf area and foliar ...

Plasma bubbles and the “engine” of fast radio bursts

Plasma bubbles and the “engine” of fast radio bursts
2024-08-07
Rome, 7 August 2024 -- Fast Radio Bursts (FRBs) are one of the most recent open mysteries of modern astrophysics. Within a few milliseconds, these powerful events release an immense amount of energy, among the highest observable in cosmic phenomena. FRBs were discovered just over ten years ago and mostly arise from extragalactic sources. Their origin, however, is still uncertain and there are huge ongoing efforts by the astrophysics community around the world to understand the physical processes behind them. In very few cases, the rapid flash that characterises FRBs coincides with a persistent ...

Microbes and their interactions the focus of major international meeting

Microbes and their interactions the focus of major international meeting
2024-08-07
One of the academic world’s largest international meetings addressing topics in microbial ecology, the 19th International Symposium on Microbial Ecology (ISME), will take place in Cape Town, South Africa in August. More than 1 500 scientists from over 50 countries worldwide will convene at the Cape Town International Convention Centre (CT-ICC) from 18 to 23 August 2024. This will be the first time that this prestigious meeting is held on the African continent. Prof. Thulani Makhalanyane, chair of the ISME organising committee and professor of microbiology at Stellenbosch University (SU), ...

Heart and brain axis targets in CNS neurological disorders

2024-08-07
Recent advancements highlight the intricate interplay between the heart and brain, underscoring their profound influence on each other, especially concerning central nervous system (CNS) neurological disorders. In light of this, a new special issue aims to explore therapeutic targets that impact both cardiac and cerebral functions. By focusing on these targets, the issue seeks to provide an in-depth understanding of the complex relationship between these vital organs. For more information and to contribute ...

Digital Science appoints new Chief People Officer

Digital Science appoints new Chief People Officer
2024-08-07
Digital Science, a technology company serving stakeholders across the research ecosystem, is pleased to announce that highly experienced human resources leader and author Claire Fox has been appointed to the role of Chief People Officer. Claire joins the Digital Science Executive Team at a time of growth for the company, with its continued mission to drive progress for all through research and innovation.  Based in London, UK, Claire has more than 20 years’ HR experience, initially in national, European and global HR leadership roles in the fast-moving consumer goods (FMCG) sector at Unilever. She then moved into international development, with senior leadership roles including ...

West Health and UC San Diego Health partnership helps California lead nation with most accredited geriatric emergency departments

2024-08-07
SAN DIEGO – AUGUST 7, 2024 – West Health and UC San Diego Health announced today that nearly three million older adults in California now have access to specialized care for medical emergencies, making the state the nation’s leader in accredited geriatric emergency departments (GEDs). Nearly half of the state’s seniors now have access to a GED compared to about 30% of seniors nationwide.  UC San Diego Health and West Health collaborated and collectively engaged more than 650 ...

Social rank may determine if animals live fast, die young

Social rank may determine if animals live fast, die young
2024-08-07
Anyone who has picnicked on the beach has experienced the unpleasant crunch of a sandwich with a surprise helping of sand. But for primates, the tolerance for sand may depend on whether their energy is better spent reproducing and fighting rivals or on protecting their teeth from a mouthful of grit, according to a new Dartmouth study. Social rank may determine whether animals prioritize immediate energy consumption over long-term health, or vice versa, the researchers report in the journal eLife. They observed the eating habits of long-tailed ...

Cutting-edge 3D-printed microneedle technology revolutionizes remote healthcare

2024-08-07
Los Angeles, California – August 6, 2024 - In a significant leap forward for healthcare equity and accessibility, researchers at the University of Victoria and the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary system that combines remote health monitoring and drug delivery using 3D-printed hollow microneedles. This innovative approach, detailed in a recent study published in Advanced Healthcare Materials, promises to transform healthcare delivery, particularly for those in underserved or remote regions. The ...

Blood test can help predict chronic lung disease in preterm babies

2024-08-07
A blood test can help predict which preterm babies will go onto develop chronic lung disease, allowing for earlier diagnosis and more targeted treatments, according to a new study. The research, led by Murdoch Children’s Research Institute (MCRI) and published in the American Journal of Respiratory Cell and Molecular Biology found that changes in certain blood proteins, alongside gestational age, birth weight and sex, strongly predicated bronchopulmonary dysplasia (BPD) within 72 hours of life. BPD usually occurs when a baby’s lungs are damaged by respiratory support and the long-term ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Cocaine discovery could pave way for treatment for substance abuse